Met Life Investment Management, LLC Codiak Bio Sciences, Inc. Transaction History

Met Life Investment Management, LLC

  • $16.6 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$10.0 - $16.78 $68,090 - $114,255
-6,809 Closed
0 $0
Q3 2021

May 17, 2024
BUY
$15.58 - $22.88 $106,084 - $155,789
6,809 New
6,809 $111,000
Q3 2021

Jun 21, 2023
BUY
$15.58 - $22.88 $106,084 - $155,789
6,809 New
6,809 $111,000
Q3 2021

Mar 22, 2023
BUY
$15.58 - $22.88 $106,084 - $155,789
6,809 New
6,809 $111,000
Q3 2021

Nov 15, 2021
BUY
$15.58 - $22.88 $106,084 - $155,789
6,809 New
6,809 $111,000

Others Institutions Holding CDAK

# of Institutions
1
Shares Held
238K
Call Options Held
0
Put Options Held
0
View Full List

About Codiak BioSciences, Inc.

CDAK Quotes by TradingView
  • Ticker CDAK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,995,200
  • Market Cap $360K
  • Description
  • Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of...
More about CDAK
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email